Connect Biopharma Holdings
CNTB
41 hedge funds and large institutions have $32.4M invested in Connect Biopharma Holdings in 2026 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 3 closing their positions.
400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 3
129% more call options, than puts
Call options by funds: $526K | Put options by funds: $230K
41% more funds holding
Funds holding: 29 → 41 (+12)
36% more capital invested
Capital invested by funds: $23.9M → $32.4M (+$8.5M)
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
7.66% more ownership
Funds ownership: 15.14% → 22.8% (+7.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
+$2.35M |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$1.94M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.56M |
| 4 |
Millennium Management
New York
|
+$1.11M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$808K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$228K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$163K |
| 3 |
Jane Street
New York
|
-$111K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$61K |
| 5 |
Renaissance Technologies
New York
|
-$58.4K |
CNTB Hedge Fund Activity: Q1 2026 in Review
41 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Connect Biopharma Holdings (CNTB) for Q1 2026, worth a combined $32.4M — up 36% from $23.9M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new CNTB positions and 3 closed out — a net gain of 12 holders — while 9 added to existing stakes and 7 trimmed.
The largest buyer was 683 Capital Management, opening a new position worth an estimated $2.35M. The largest seller was OMERS Administration Corp, exiting entirely with an estimated $228K sold.
- 41 institutional investors held Connect Biopharma Holdings (CNTB) as of Q1 2026, up from 29 in Q4 2025.
- Funds reported $32.4M of Connect Biopharma Holdings stock for Q1 2026, up 36% quarter-over-quarter.
- 15 funds opened new Connect Biopharma Holdings positions in Q1 2026 and 3 closed out, a net change of +12 holders.
- The largest Connect Biopharma Holdings buyer in Q1 2026 was 683 Capital Management, an estimated $2.35M added.
- The largest Connect Biopharma Holdings seller in Q1 2026 was OMERS Administration Corp, an estimated $228K sold.
Based on aggregated 13F filings for Q1 2026.